COVID-19 Switzerland
Information on the current situation, as of 17 May 2022
The key figures will be published each Tuesday at 15:30.
Status report, Switzerland and Liechtenstein
Laboratory-confirmed cases
Source: FOPH – Status: 17.05.2022, 06.08h
| Difference since 10.05.2022 | 10 788 |
|---|---|
| 14-day incidence from 11.05.2022Total per 100 000 inhabitants | 309,13 |
| Total since 24.02.2020 | |
| Number of cases | 3 659 935 |
| Per 100 000 inhabitants | 42 023,03 |
Cases
Newly reported
7-day average
Laboratory-confirmed hospitalisations
Source: FOPH – Status: 17.05.2022, 06.08h
| Difference since 10.05.2022 | 150 |
|---|---|
| 14-day incidence from 11.05.2022Total per 100 000 inhabitants | 3,59 |
| Total since 24.02.2020 | |
| Number of hospitalisations | 53 152 |
| Per 100 000 inhabitants | 610,29 |
Cases
Newly reported
7-day average
Laboratory-confirmed deaths
Source: FOPH – Status: 17.05.2022, 06.08h
| Difference since 10.05.2022 | 12 |
|---|---|
| 14-day incidence from 11.05.2022Total per 100 000 inhabitants | 0,37 |
| Total since 24.02.2020 | |
| Number of deaths | 13 314 |
| Per 100 000 inhabitants | 152,87 |
Cases
Newly reported
7-day average
Vaccinated people
Source: FOPH – Status: 17.05.2022, 07.00h
| Total population | |
|---|---|
| People with at least one dose | 70,15% |
| Partially vaccinated | 0,99% |
| Fully vaccinated | 69,16% |
| With booster vaccination | 43,16% |
Hospital capacity, Switzerland
Source: FOPH – Status: 17.05.2022, 09.08h
| Intensive care units | |
|---|---|
| Occupancy by COVID-19 patients15-day average from 09.05.2022 | 51,07 |
| Total occupancy | 73,10% |
| Occupancy by COVID-19 patients | 5,30% |
| Total hospital capacity | |
| Total occupancy | 80,30% |
| Occupancy by COVID-19 patients | 2,10% |
15-day average
COVID-19
Non-COVID-19
Free beds
Number of beds and occupancy in intensive care units
Virus variants
Source: FOPH – Status: 17.05.2022, 06.08h
Following the lifting of the special situation, the monitoring of variants of the virus will be adapted. There will be fewer numbers of samples sequenced and reporting delays are to be expected.
Estimated share of the different virus variants, 7-day average.
| B.1.351 – Beta7-day average from 09.04.2022 | 0,0% |
|---|---|
| P.1 – Gamma7-day average from 09.04.2022 | 0,0% |
| B.1.617.2, all subvariants AY – Delta7-day average from 09.04.2022 | 0,0% |
| C.37 – Lambda7-day average from 09.04.2022 | 0,0% |
| B.1.1.529 – Omicron7-day average from 09.04.2022 | 99,0% |
Tests and share of positive tests
Source: FOPH – Status: 17.05.2022, 06.08h
| Difference since 10.05.2022 | 64 409 |
|---|---|
| Total since 06.02.2020 | 21 476 194 |
| PCR tests | 16 234 425 |
| Rapid antigen tests | 5 241 769 |
| Per 100 000 inhabitantsCumulative PCR and rapid antigen tests | 246 587,65 |
| Share of positive PCR tests | 21,7% |
| Share of positive rapid antigen tests | 11,5% |
7-day average